Patriot Financial Group Insurance Agency’s Elicio Therapeutics ELTX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,450	Closed	-$14.2K	–	473
2023 Q1	$14.2K	Buy	2,450 +300	+14%	+$2K	﹤0.01%	455
2022 Q4	$17.4K	Sell	2,150 -1,500	-41%	-$13.6K	﹤0.01%	426
2022 Q3	$34K	Hold	3,650	–	–	0.01%	393
2022 Q2	$41K	Buy	3,650 +300	+9%	+$4.79K	0.01%	791
2022 Q1	$71K	Buy	+3,350	New	+$75.6K	0.01%	679

Other funds holding ELTX

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MHC

Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ELTX Position: Q2 2023 in Review

Patriot Financial Group Insurance Agency sold out of Elicio Therapeutics (ELTX) in Q2 2023, closing a stake of 2,450 shares — an estimated $14.2K sold.

Patriot Financial Group Insurance Agency first reported a position in ELTX in Q1 2022 and held it in 5 quarters. The position peaked at $71K in Q1 2022. 15 funds tracked by Wall St. Rank hold ELTX as of Q2 2023.

Patriot Financial Group Insurance Agency reported no remaining Elicio Therapeutics position as of Q2 2023 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 2,450 Elicio Therapeutics shares in Q2 2023, an estimated $14.2K.
Patriot Financial Group Insurance Agency first reported a position in Elicio Therapeutics in Q1 2022 and held it in 5 quarters.
Patriot Financial Group Insurance Agency's Elicio Therapeutics position peaked at $71K in Q1 2022.
15 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2023.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2023, filed 17 Jul 2023.